La Trobe study finds persistent gaps in HIV testing and prevention
A new La Trobe University report shows that despite treatment advances, some people remain vulnerable because of uneven access to testing and prevention.
A report from La Trobe University highlights that progress in HIV treatment and care has not eliminated gaps in testing, diagnosis, and prevention. The researchers found that some people are still being left vulnerable to infection, even though major medical advances exist.
The study points to uneven access and uptake of prevention tools and testing services. While the report does not single out a single cause, it suggests that current approaches are not fully reaching all populations, leaving pockets of risk.
The findings imply that closing these gaps will require more than just medical innovation—it will need targeted public health efforts to ensure testing and prevention are available and used by everyone who could benefit.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.